Article
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
1 Sept 2002
Abstract excerpt
This study investigated whether patients developing pulmonary arterial hypertension (PAH) after exposure to the appetite suppressants fenfluramine and dexfenfluramine have mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene, as reported in primary pulmonary hypertension. BMPR2 was examined for mutations in 33 unrelated patients with sporadic PAH, and in two sisters with PAH, all of whom had taken...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
